Updated Jul 16, 2026
SEVERINO MICHAEL has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Michael Severino is an executive known for his role at Viatris Inc, a global healthcare company formed through the merger of Mylan and Upjohn, a division of Pfizer. He has held various leadership positions within the pharmaceutical industry, focusing on strategic development and operations.
| Role | Director |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-11 | AVTR | Avantor, Inc. | A — Grant or award | 25.3K | $0.00 | |
| 2026-03-10 | VTRS | Viatris Inc | M — Option exercise | 919 | $0.00 | |
| 2026-03-10 | VTRS | Viatris Inc | M — Option exercise | 25.1K | $0.00 |
Michael Severino is an executive known for his role at Viatris Inc, a global healthcare company formed through the merger of Mylan and Upjohn, a division of Pfizer. He has held various leadership positions within the pharmaceutical industry, focusing on strategic development and operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SEVERINO MICHAEL profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.